Bio-Techne (TECH) Change in Accured Expenses (2009 - 2026)
Bio-Techne's quarterly Change in Accured Expenses came in at $17.8 million in Q1 2026, up 3010.66% year-on-year from $570780.0 in Q1 2025, and up 1174.59% quarter-over-quarter from $1.4 million in Q4 2025.
Bio-Techne has reported Change in Accured Expenses for 18 years, with the latest figure at $17.8 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 3010.66% year-over-year to $17.8 million; the trailing twelve-month figure through Mar 2026 stood at -$16.3 million (down 190.54% YoY), and the FY2025 full-year result was -$14.0 million, down 154.15% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at $17.8 million, up from $1.4 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $18.6 million in Q2 2024, with the low at -$28.4 million in Q3 2022.
- Average Change in Accured Expenses over 5 years is $815882.4, with a median of $1.8 million recorded in 2024.
- Year-over-year, Change in Accured Expenses plunged 205.97% in 2024 and soared 3010.66% in 2026.
- Tracing TECH's Change in Accured Expenses over 5 years: stood at $16.8 million in 2022, then plunged by 51.98% to $8.1 million in 2023, then grew by 1.73% to $8.2 million in 2024, then plunged by 83.05% to $1.4 million in 2025, then soared by 1174.59% to $17.8 million in 2026.
- The last three Change in Accured Expenses figures came in at $17.8 million (Q1 2026), $1.4 million (Q4 2025), and -$22.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 931,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 70.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -176.03 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 17.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.76 Mn |
| Mar 31, 2026 | 17.76 Mn |
| Dec 31, 2025 | 1.39 Mn |
| Dec 31, 2025 | 1.39 Mn |
| Sep 30, 2025 | -22.10 Mn |
| Sep 30, 2025 | -22.10 Mn |
| Jun 30, 2025 | -13.32 Mn |
| Jun 30, 2025 | -13.32 Mn |
| Mar 31, 2025 | -610,000.00 |
| Mar 31, 2025 | -610,000.00 |
| Dec 31, 2024 | 8.22 Mn |
| Dec 31, 2024 | 8.22 Mn |
| Sep 30, 2024 | -8.25 Mn |
| Sep 30, 2024 | -8.25 Mn |
| Jun 30, 2024 | 18.61 Mn |
| Jun 30, 2024 | 18.61 Mn |
| Mar 31, 2024 | 1.78 Mn |
| Mar 31, 2024 | 1.78 Mn |
| Dec 31, 2023 | 8.08 Mn |
| Dec 31, 2023 | 8.08 Mn |
| Sep 30, 2023 | -2.70 Mn |
| Sep 30, 2023 | -2.70 Mn |
| Jun 30, 2023 | -2.26 Mn |
| Jun 30, 2023 | -2.26 Mn |
| Mar 31, 2023 | 5.89 Mn |
| Mar 31, 2023 | 5.89 Mn |
| Dec 31, 2022 | 16.82 Mn |
| Dec 31, 2022 | 16.82 Mn |
| Sep 30, 2022 | -28.36 Mn |
| Sep 30, 2022 | -28.36 Mn |
| Jun 30, 2022 | 10.68 Mn |
| Jun 30, 2022 | 10.68 Mn |
| Mar 31, 2022 | 2.23 Mn |
| Mar 31, 2022 | 2.23 Mn |
| Dec 31, 2021 | 18.76 Mn |
| Dec 31, 2021 | 18.76 Mn |
| Sep 30, 2021 | -18.93 Mn |
| Sep 30, 2021 | -18.93 Mn |
| Jun 30, 2021 | 6.89 Mn |
| Jun 30, 2021 | 6.89 Mn |
| Mar 31, 2021 | 3.57 Mn |
| Mar 31, 2021 | 3.57 Mn |
| Dec 31, 2020 | 1.71 Mn |
| Dec 31, 2020 | 1.71 Mn |
| Sep 30, 2020 | 6.92 Mn |
| Sep 30, 2020 | 6.92 Mn |
| Jun 30, 2020 | 7.64 Mn |
| Jun 30, 2020 | 7.64 Mn |
| Mar 31, 2020 | -12.21 Mn |
| Mar 31, 2020 | -12.21 Mn |
| Dec 31, 2019 | 18.10 Mn |
| Dec 31, 2019 | 18.10 Mn |
| Sep 30, 2019 | -10.98 Mn |
| Sep 30, 2019 | -10.98 Mn |
| Jun 30, 2019 | -1.88 Mn |
| Jun 30, 2019 | -1.88 Mn |
| Mar 31, 2019 | 11.91 Mn |
| Mar 31, 2019 | 11.91 Mn |
| Dec 31, 2018 | 4.54 Mn |
| Dec 31, 2018 | 4.54 Mn |
| Sep 30, 2018 | -8.48 Mn |
| Sep 30, 2018 | -8.48 Mn |
| Jun 30, 2018 | 4.07 Mn |
| Jun 30, 2018 | 4.07 Mn |
| Mar 31, 2018 | -4.61 Mn |
| Mar 31, 2018 | -4.61 Mn |
| Dec 31, 2017 | 1.02 Mn |
| Dec 31, 2017 | 1.02 Mn |
| Sep 30, 2017 | -563,000.00 |
| Sep 30, 2017 | -563,000.00 |
| Jun 30, 2017 | -1.64 Mn |
| Jun 30, 2017 | -1.64 Mn |
| Mar 31, 2017 | 2.56 Mn |
| Mar 31, 2017 | 2.56 Mn |
| Dec 31, 2016 | 6.12 Mn |
| Dec 31, 2016 | 6.12 Mn |
| Sep 30, 2016 | -6.37 Mn |
| Sep 30, 2016 | -6.37 Mn |
| Jun 30, 2016 | 3.83 Mn |
| Jun 30, 2016 | 3.83 Mn |
| Mar 31, 2016 | 3.97 Mn |
| Mar 31, 2016 | 3.97 Mn |
| Dec 31, 2015 | -367,000.00 |
| Dec 31, 2015 | -367,000.00 |
| Sep 30, 2015 | -1.70 Mn |
| Sep 30, 2015 | -1.70 Mn |
| Jun 30, 2015 | 664,000.00 |
| Jun 30, 2015 | 664,000.00 |
| Mar 31, 2015 | 533,000.00 |
| Mar 31, 2015 | 533,000.00 |
| Dec 31, 2014 | -1.57 Mn |
| Dec 31, 2014 | -1.57 Mn |
| Sep 30, 2014 | 2.53 Mn |
| Sep 30, 2014 | 2.53 Mn |
| Jun 30, 2014 | 459,000.00 |
| Jun 30, 2014 | 459,000.00 |
| Mar 31, 2014 | 1.57 Mn |
| Mar 31, 2014 | 1.57 Mn |
| Dec 31, 2013 | -2.41 Mn |
| Dec 31, 2013 | -2.41 Mn |
| Sep 30, 2013 | 1.42 Mn |
| Sep 30, 2013 | 1.42 Mn |
| Jun 30, 2013 | -393,000.00 |
| Jun 30, 2013 | -393,000.00 |
| Mar 31, 2013 | 1.03 Mn |
| Mar 31, 2013 | 1.03 Mn |
| Dec 31, 2012 | -608,000.00 |
| Dec 31, 2012 | -608,000.00 |
| Sep 30, 2012 | 218,000.00 |
| Sep 30, 2012 | 218,000.00 |
| Jun 30, 2012 | 230,000.00 |
| Jun 30, 2012 | 230,000.00 |
| Mar 31, 2012 | -84,000.00 |
| Mar 31, 2012 | -84,000.00 |
| Dec 31, 2011 | 610,000.00 |
| Dec 31, 2011 | 610,000.00 |
| Sep 30, 2011 | 825,000.00 |
| Sep 30, 2011 | 825,000.00 |
| Jun 30, 2011 | -118,000.00 |
| Jun 30, 2011 | -118,000.00 |
| Mar 31, 2011 | 2.23 Mn |
| Mar 31, 2011 | 2.23 Mn |
| Dec 31, 2010 | -547,000.00 |
| Dec 31, 2010 | -547,000.00 |
| Sep 30, 2010 | -295,000.00 |
| Sep 30, 2010 | -295,000.00 |
| Jun 30, 2010 | -747,000.00 |
| Jun 30, 2010 | -747,000.00 |
| Mar 31, 2010 | 954,000.00 |
| Mar 31, 2010 | 954,000.00 |
| Dec 31, 2009 | -583,000.00 |
| Dec 31, 2009 | -583,000.00 |
| Sep 30, 2009 | 302,000.00 |
| Sep 30, 2009 | 302,000.00 |